ABBOTT M2000SP
Report
- Report Number
- 3005248192-2014-00058
- Event Type
- Malfunction
- Date Received
- October 3, 2014
- Date of Event
- September 2, 2014
- Report Date
- September 4, 2014
- Manufacturer
- ABBOTT MOLECULAR, INC.
- Product Code
- JJH
- PMA / PMN Number
- K092705
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- RP
- Reporter Occupation
- PHYSICIAN
Narratives
THE ELEVATED COMPLAINT INVESTIGATION (ECINV) FOR (B)(4) DETERMINED THIS COMPLAINT IS THE SAME ISSUE AS THAT OF (B)(4). SUMMARY OF ELEVATED COMPLAINT INVESTIGATION (B)(4): PROBLEM: EXCESSIVE NOISE FROM THE LIHA AND ROMA X-DRIVE MOTORS WAS REPORTED. NOISE AND STEP-LOSS FAILURES OCCUR WITHIN 2-3 MONTHS OF INSTRUMENT INSTALLATION OR REPLACEMENT SPARE PART INSTALLATION. CONCLUSIONS: RETAIN TESTING OF THE X-DRIVE MOTOR WAS NOT APPLICABLE AS NO FILE SAMPLES ARE RETAINED. SUPPLIER (B)(4) HAS CONFIRMED A PRODUCT DEFICIENCY WITH THE DRIVE BELT PRODUCTION PROCESS ON SOME BELTS. WITHIN (B)(4) OF OPERATION THE BELT TENSION CHANGES LEADING TO EXCESSIVE NOISE AND IN SOME CASES THE ASSOCIATED ARM CRASHES INTO A WORKTABLE OBJECT OR BECOMES MISALIGNED. X-DRIVE AXIS MOTOR REPLACEMENT SPARE PARTS AND ALL M2000SP AND M24SP INSTRUMENTS MANUFACTURED WITH THE ASSEMBLIES WITH DATE CODES BETWEEN (B)(4) ARE SUSPECT. THE M2000SP SERVICE MANUAL CONTAINS ADEQUATE INSTRUCTIONS FOR TROUBLESHOOTING X-DRIVE MOTOR ISSUES WITH REPLACEMENT INSTRUCTIONS AND PART NUMBER INFORMATION. VALID MATERIAL SPECIFICATIONS ARE RESIDENT IN PILGRIM SMARTSOLVE FOR THE MOTOR DC ARM X-AXIS 1000 INCREMENTS EVO PART NUMBER 10649045. A THOROUGH COMPLAINT SEARCH WAS PERFORMED TO IDENTIFY PAST COMPLAINT TICKETS FROM THE LAST TWO YEARS FOR ANY INSTANCES OF THE X-DRIVE MOTORS MAKING EXCESSIVE NOISE ON THE M2000SP INSTRUMENT. COMPLAINT HISTORY REVIEW SHOWED THAT, OVER THE LAST TWO YEARS, (B)(4). ELEVATED COMPLAINT INVESTIGATION (B)(4) CONCLUDED THERE WAS A CONFIRMED PRODUCT DEFICIENCY WITH THE X-DRIVE MOTOR PART NUMBER 10649045. ABBOTT MOLECULAR DETERMINED A FIELD ACTION (CORRECTION) SHOULD BE TAKEN TO INSPECT AND, IF NECESSARY, REPLACE THE AFFECTED BELTS. ABBOTT MOLECULAR INITIATED FIELD ACTION NUMBER (B)(4) ON (B)(4) 2013 AS A RECORDABLE FIELD ACTION. UPON RECEIPT OF (B)(4)ON (B)(4) 2014, ABBOTT MOLECULAR DETERMINED THIS FIELD ACTION SHOULD HAVE BEEN REPORTED TO FDA PER 21 CFR 806, AND ON (B)(4) 2014 REPORTED IT TO THE FDA (B)(4) DISTRICT RECALL COORDINATOR. THEREFORE, THE PURPOSE OF SUBMITTING MDR 3005248192-2014-00058 IS TO RETROSPECTIVELY REPORT THIS COMPLAINT BECAUSE IT IS ASSOCIATED WITH REPORTABLE FIELD ACTION (B)(4) (806 REPORT NUMBER 3005248192-07/28/2014-002-C). TO DATE, AN FDA RECALL NUMBER HAS NOT BEEN RECEIVED. THE FOLLOWING MDRS WERE ALSO REPORTED: MDR 3005248192-2014-00007, MDR 3005248192-2014-00008, MDR 3005248192-2014-00009, MDR 3005248192-2014-00010, MDR 3005248192-2014-00011, MDR 3005248192-2014-00012, MDR 3005248192-2014-00013, MDR 3005248192-2014-00014, MDR 3005248192-2014-00015, MDR 3005248192-2014-00016, MDR 3005248192-2014-00017, MDR 3005248192-2014-00018, MDR 3005248192-2014-00019, MDR 3005248192-2014-00020, MDR 3005248192-2014-00021, MDR 3005248192-2014-00022, MDR 3005248192-2014-00023, MDR 3005248192-2014-00024, MDR 3005248192-2014-00025, MDR 3005248192-2014-00026, MDR 3005248192-2014-00027, MDR 3005248192-2014-00028, MDR 3005248192-2014-00029, MDR 3005248192-2014-00030, MDR 3005248192-2014-00031, MDR 3005248192-2014-00032, MDR 3005248192-2014-00033, MDR 3005248192-2014-00034, MDR 3005248192-2014-00035, MDR 3005248192-2014-00036, MDR 3005248192-2014-00037, MDR 3005248192-2014-00038, MDR 3005248192-2014-00039, MDR 3005248192-2014-00040, MDR 3005248192-2014-00041, MDR 3005248192-2014-00042, MDR 3005248192-2014-00043, MDR 3005248192-2014-00044, MDR 3005248192-2014-00045, MDR 3005248192-2014-00046, MDR 3005248192-2014-00047, MDR 3005248192-2014-00048, MDR 3005248192-2014-00049, MDR 3005248192-2014-00050, MDR 3005248192-2014-00051, MDR 3005248192-2014-00052, MDR 3005248192-2014-00053, MDR 3005248192-2014-00054, MDR 3005248192-2014-00055.
THE ABBOTT M2000 SYSTEM IS INTENDED FOR USE IN PERFORMING NUCLEIC ACID AMPLIFICATION TESTING BY POLYMERASE CHAIN REACTION IN CLINICAL LABORATORIES. THE SYSTEM IS COMPOSED OF THE M2000RT AND THE M2000SP INSTRUMENTS. THE M2000SP IS INTENDED FOR AUTOMATED SAMPLE PREPARATION AND NUCLEIC ACID EXTRACTION PRIOR TO TESTING. THE ABBOTT M24SP IS A CE-MARKED EXTRACTION INSTRUMENT SIMILAR TO THE ABBOTT M2000SP INSTRUMENT. THE INSTRUMENT INVOLVED IN THIS COMPLAINT IS AN M24SP (LIST 03N06-01), SERIAL NUMBER (B)(4). AN ABBOTT FIELD SERVICE ENGINEER (FSE) PERFORMED (B)(4) AND OBSERVED CORROSION ON THE LIHA X-DRIVE BELT. THE FSE REPLACED THE LIHA X-DRIVE BELT PER (B)(4). THERE WAS NOT ANY REPORT OF HARM. ELEVATED COMPLAINT INVESTIGATION (B)(4) CONFIRMED THAT THIS COMPLAINT IS LINKED TO A KNOWN PRODUCT MALFUNCTION OF THE X-DRIVE MOTOR. MEDICAL EVALUATION CONCLUDED THIS ISSUE IS NOT LIKELY TO CAUSE OR CONTRIBUTE TO DEATH OR SERIOUS INJURY. THIS COMPLAINT IS REPORTED IN ACCORDANCE WITH 21 CFR 803 ON THE BASIS IT IS LINKED TO REPORTABLE FIELD ACTION (B)(4), PER 21 CFR 806.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 620849 | ABBOTT M2000SP | CLINICAL SAMPLE CONCENTRATOR | JJH | ABBOTT MOLECULAR, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |